Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/CT vs. PET/MRI in Cancer Patients
NCT03125629Phase 2Completed
- Sponsor
- Stanford University
- Start
- May 2014
- Primary completion
- Nov 2016
- Countries
- 1
01
Overview
Phase 2, open-label trial in cancer, sponsored by Stanford University. Primary endpoint: Absolute Accuracy of SUV Max of PET/CT vs PET/MRI at 4 hours. Started May 2014; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on NCT03125629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03125629.